Clinical trials: Intra-dialytic Hypotension
Intra-dialytic Hypotension
Trial of Dialysate Sodium in Chronic Hospitalized Hemodialysis Patients
Intra-dialytic hypotensive (IDH) events can be defined as an abrupt decline in blood pressure that cause symptoms and/or require an intervention. They are common, affecting up to one third of maintenance HD sessions.
- Trial name
- NCT02145260
- Testing
- Lower dialysate sodium (138 mmol/L; using Renasol hemodialysis concentrate), Higher dialysate sodium (142 mmol/L; using Renasol hemodialysis concentrate)
- Where
- United States
- Volunteers
- 144 people
- Sponsor
- Brigham and Women's Hospital
Intra-dialytic Hypotension
Mannitol - Potential Role in Hemodialysis Initiation for Reduction of Intra-dialytic Hypotension
Kidney failure can result from a variety of conditions and can be temporary or permanent. Hemodialysis is available as a replacement treatment to perform the work that the kidneys normally do.
- Trial name
- NCT01520207
- Testing
- Mannitol (20%), 0.9% saline
- Where
- United States
- Volunteers
- 52 people
- Sponsor
- Brigham and Women's Hospital